Market Overview:
The global cannabinoid-based products for cancer market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of cancer, rising awareness about the benefits of cannabinoids in treating various types of cancers, and growing demand for cannabis-based therapies. The global cannabinoid-based products for cancer market is segmented on the basis of type into smoking products, food products, oil, coat product, and other. On the basis of application, it is segmented into clinics, hospitals and others. Regionally speaking North America dominates this market followed by Europe and Asia Pacific respectively while Latin America and Middle East & Africa are projected to exhibit high growth rates over the forecast period owing to increasing legalization initiatives pertaining cannabis across these regions.
Product Definition:
Cannabinoid-based products for cancer are products that contain cannabinoids, which are chemicals found in cannabis plants. Cannabinoids have been shown to kill cancer cells in lab tests and to reduce tumor growth in animal models of cancer. They may also help relieve symptoms associated with cancer treatment, such as nausea and vomiting.
Smoking Products:
Smoking products are divided into two types: Marijuana and Tobacco. The marijuana segment is expected to grow at a rapid rate owing to the increasing legalization of medical cannabis across various countries. In addition, the growing number of cancer patients who are prescribed medicinal cannabis for treatment is further driving this market.
Food Products:
Food products and its usage in cannabinoid-based products for cancer market is a research based on the potential of Cannabinoids (CB) to modulate and act as anti-cancer agents. CB are naturally occurring compounds found in the cannabis plant. They are mainly extracted from two sources, namely, marijuana and hemp plants.
Application Insights:
Based on application, the market is segmented into clinics, hospitals and other healthcare facilities, others. The clinics segment dominated the overall industry in terms of revenue in 2017. Increasing awareness regarding cancer and rising availability of advanced treatment options are factors contributing to growth. Moreover, an increase in investment by governments for developing cancer treatment centers is expected to boost demand over the forecast period.
The hospital and other healthcare facility category accounted for a significant share of 29% in 2017 owing to growing government initiatives toward improving care standards at these facilities across various regions coupled with increasing investments by companies operating within this sector such as GW Pharmaceuticals Plc., Insys Therapeutics Inc., Medivation Inc., Mavyale Ltd.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period owing to presence of key players, favorable government policies and increasing demand for cannabis-based products. For instance, in 2018, Canada legalized marijuana for recreational use which is anticipated to increase product adoption over the coming years.
Asia Pacific is expected to witness significant growth over the forecast period due to rising number of cancer patients and awareness about early diagnosis coupled with high economic development in some Asian countries such as China and India. In addition, increasing legalization & decriminalization of cannabis acts as a major driver for regional growth.
Growth Factors:
- Increasing legalization of medical cannabis for cancer treatment across the globe.
- Growing research on the potential benefits of cannabinoids in cancer treatment.
- Rising demand for cannabinoid-based products from cancer patients and their caregivers.
- increasing investment by pharmaceutical companies in cannabinoid-based drug development programs.
Scope Of The Report
Report Attributes
Report Details
Report Title
Cannabinoid-based Products for Cancer Market Research Report
By Type
Smoking Products, Food Products, Oil, Coat Product, Other
By Application
Clinics, Hospitals, Others
By Companies
Bausch Health, GW Pharmaceuticals, Cannabics Inc., Tikun Olam, Jay Pharma
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
123
Number of Tables & Figures
87
Customization Available
Yes, the report can be customized as per your need.
Global Cannabinoid-based Products for Cancer Market Report Segments:
The global Cannabinoid-based Products for Cancer market is segmented on the basis of:
Types
Smoking Products, Food Products, Oil, Coat Product, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Clinics, Hospitals, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Bausch Health
- GW Pharmaceuticals
- Cannabics Inc.
- Tikun Olam
- Jay Pharma
Highlights of The Cannabinoid-based Products for Cancer Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Smoking Products
- Food Products
- Oil
- Coat Product
- Other
- By Application:
- Clinics
- Hospitals
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Cannabinoid-based Products for Cancer Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Cannabinoid-based products are medications or supplements that contain cannabinoids, including CBD and THC. These products are often used to treat cancer because they can help reduce inflammation and pain, as well as improve the quality of life for patients.
Some of the major players in the cannabinoid-based products for cancer market are Bausch Health, GW Pharmaceuticals, Cannabics Inc., Tikun Olam, Jay Pharma.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Cannabinoid-based Products for Cancer Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Cannabinoid-based Products for Cancer Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Cannabinoid-based Products for Cancer Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Cannabinoid-based Products for Cancer Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Cannabinoid-based Products for Cancer Market Size & Forecast, 2020-2028
4.5.1 Cannabinoid-based Products for Cancer Market Size and Y-o-Y Growth
4.5.2 Cannabinoid-based Products for Cancer Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Smoking Products
5.2.2 Food Products
5.2.3 Oil
5.2.4 Coat Product
5.2.5 Other
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Clinics
6.2.2 Hospitals
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Cannabinoid-based Products for Cancer Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Cannabinoid-based Products for Cancer Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Smoking Products
9.6.2 Food Products
9.6.3 Oil
9.6.4 Coat Product
9.6.5 Other
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Clinics
9.10.2 Hospitals
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Smoking Products
10.6.2 Food Products
10.6.3 Oil
10.6.4 Coat Product
10.6.5 Other
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Clinics
10.10.2 Hospitals
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Smoking Products
11.6.2 Food Products
11.6.3 Oil
11.6.4 Coat Product
11.6.5 Other
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Clinics
11.10.2 Hospitals
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Smoking Products
12.6.2 Food Products
12.6.3 Oil
12.6.4 Coat Product
12.6.5 Other
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Clinics
12.10.2 Hospitals
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Smoking Products
13.6.2 Food Products
13.6.3 Oil
13.6.4 Coat Product
13.6.5 Other
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Clinics
13.10.2 Hospitals
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Cannabinoid-based Products for Cancer Market: Competitive Dashboard
14.2 Global Cannabinoid-based Products for Cancer Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Bausch Health
14.3.2 GW Pharmaceuticals
14.3.3 Cannabics Inc.
14.3.4 Tikun Olam
14.3.5 Jay Pharma
